Based on current trends, almost all African countries are likely to report over 1 000 COVID-19 cases by the end of April 2020, and over 10 000 a few weeks after that
View ORCID ProfileCarl A. B. Pearson, View ORCID ProfileCari Van Schalkwyk, Anna M. Foss, View ORCID ProfileKathleen M. O’Reilly, SACEMA Modelling and Analysis Response Team, CMMID COVID-19 working group, View ORCID ProfileJuliet R. C. Pulliam
doi: https://doi.org/10.1101/2020.04.05.20054403
Carl A. B. Pearson
1London School of Hygiene & Tropical Medicine, London, UK
2South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, RSA
Cari Van Schalkwyk
2South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, RSA
Anna M. Foss
1London School of Hygiene & Tropical Medicine, London, UK
Kathleen M. O’Reilly
1London School of Hygiene & Tropical Medicine, London, UK
2South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, RSA
1London School of Hygiene & Tropical Medicine, London, UK
Juliet R. C. Pulliam
2South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, RSA
Article usage
Posted April 10, 2020.
Based on current trends, almost all African countries are likely to report over 1 000 COVID-19 cases by the end of April 2020, and over 10 000 a few weeks after that
Carl A. B. Pearson, Cari Van Schalkwyk, Anna M. Foss, Kathleen M. O’Reilly, SACEMA Modelling and Analysis Response Team, CMMID COVID-19 working group, Juliet R. C. Pulliam
medRxiv 2020.04.05.20054403; doi: https://doi.org/10.1101/2020.04.05.20054403
Based on current trends, almost all African countries are likely to report over 1 000 COVID-19 cases by the end of April 2020, and over 10 000 a few weeks after that
Carl A. B. Pearson, Cari Van Schalkwyk, Anna M. Foss, Kathleen M. O’Reilly, SACEMA Modelling and Analysis Response Team, CMMID COVID-19 working group, Juliet R. C. Pulliam
medRxiv 2020.04.05.20054403; doi: https://doi.org/10.1101/2020.04.05.20054403
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2296)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11621)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3623)
- Geriatric Medicine (340)
- Health Economics (622)
- Health Informatics (2329)
- Health Policy (918)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (393)
- Neurology (3389)
- Nursing (193)
- Nutrition (512)
- Oncology (1776)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1012)
- Primary Care Research (409)
- Public and Global Health (6020)
- Radiology and Imaging (1237)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)